Clinical laboratory studies in Barth Syndrome

Area of Science:

• Biochemistry
• Genetics
• Rare Diseases

Background:

• Barth Syndrome is a rare X-linked disorder impacting cardiac and skeletal muscles, and immune function.
• It stems from tafazzin enzyme defects, crucial for cardiolipin modification.
• Existing research extensively covers clinical aspects but lacks detailed biochemical characterization.

Purpose of the Study:

• To comprehensively characterize the biochemical profile of Barth Syndrome patients.
• To identify unique biochemical markers associated with the disorder.
• To investigate whether female carriers exhibit similar biochemical abnormalities.

Main Methods:

• Analyzed plasma amino acids, 3-methylglutaconic acid, cholesterol, and cholesterol synthesis intermediates.
• Examined red blood cell membrane fatty acid profiles.
• Assessed these parameters in 28 Barth Syndrome patients and 8 female carriers.

Main Results:

• Identified a distinct biochemical profile in Barth Syndrome patients, notably decreased plasma arginine levels.
• Observed specific patterns in plasma amino acids, cholesterol, and related metabolites.
• Confirmed that female carriers do not present these Barth Syndrome-specific biochemical abnormalities.

Conclusions:

• The study establishes a unique biochemical signature for Barth Syndrome.
• Findings provide valuable insights into the underlying biochemical pathology of the disorder.
• The distinct profile observed in patients, absent in carriers, aids in understanding disease mechanisms.